Additionally, another anti-tumor agent, evodiamine (Evo), an active ingredient isolated from the fruit of Evodia rutaecarpa Bentham, has been shown to exert its antitumor activities via inhibiting the activation of NF-κB and MAPK [39,40,41]. Here, NFKB1 is linked to neoplasm.